Navigation Links
Practical Diabetology Highlights Advanced Lipid Testing for Type 2 Diabetes Patients

BIRMINGHAM, Ala., Sept. 17 /PRNewswire/ -- Detailed cholesterol testing for Type 2 diabetes patients is the focus of a newly published article by Atherotech Diagnostics Lab Chief Medical Officer Michael E. Cobble, M.D. "Advanced Lipid Testing" appears in the September/October 2010 quarterly issue of Practical Diabetology.



The article discusses the clinical advantages of advanced cholesterol testing in reducing cardiovascular disease (CVD) risk in patients with Type 2 diabetes and details several currently available advanced lipid tests, including the VAP® Cholesterol Test from Atherotech. Cobble also explores which patients are appropriate to test and how to apply advanced lipid testing results.

Advanced lipid testing is affordable, widely available and may provide valuable information in the treatment and management of people living with Type 2 diabetes, explained Cobble, who is also a director, researcher and clinician at Canyons Medical Center in Sandy, Utah.

"We know that aggressive management of multiple cardiovascular disease risks in diabetes mellitus patients has proven beneficial," Cobble said. "But in order to properly treat these patients, we first must identify them and effectively assess their risk. This is achieved through advanced lipid profiles."

Diabetes is a high-risk CVD condition that affects more than 24 million Americans, and patients with Type 2 diabetes are considered high risk due to traditional CVD risk factors and residual lipid risk factors, all of which can be determined through detailed lipoprotein assays such as the VAP Test.

"Standard lipid tests miss more than half of all at-risk patients, and may actually underestimate the number of lipoprotein particles that can lead to atherosclerotic plaques," Cobble said. "When it comes to diabetic patients, the standard test simply doesn't give us enough data to make the best decisions for our patients."

Advanced lipid tests provide a more sophisticated measurement of LDL, HDL, VLDL, non-HDL and other lipid subcomponents. The Vertical Auto Profile (VAP), for example, reports the relative distribution of cholesterol content of all lipoproteins and subfractions — 22 components of blood cholesterol to be exact — at no additional cost.

The VAP Test includes Lp(a) and reports all three lipoprotein parameters — LDL, non-HDL and apoB — considered necessary by the expert consensus guidelines issued by the American Diabetes Association and American College of Cardiology. Unlike the standard lipid profile, the VAP Test directly measures LDL and is therefore unaffected by triglycerides, allowing the test to be performed in non-fasting patients. The VAP Test reports all lipoproteins and apolipoproteins, including apoA1 and the apoB/apoA1 ratio, and it can identify triglyceride remnant markers for Metabolic Syndrome, a precursor and coexistor to diabetes.

Practical Diabetology provides practical information to physicians to enhance the care and treatment of diabetes patients. It is published quarterly and available by subscription by calling 212-989-0200. The VAP Test is available nationwide and widely covered by insurance. For more information call 877-901-8510  or visit Atherotech Diagnostics Lab is on Twitter, @Atherotech, and also on Facebook at

About Atherotech Diagnostics Lab

Atherotech is a CLIA-certified clinical reference laboratory and cardiodiagnostic company focusing on cardiometabolic tests, including the company's patented VAP Cholesterol Test, which reports the cholesterol content of all lipids, components and subclasses. The VAP Test is the first cholesterol profile to comply with updated National Cholesterol Education Program ATP III recommendations for direct LDL measurement, which is accurate with non-fasting samples. The VAP Test is available through national and regional diagnostic laboratories and is reimbursed by many of the largest private insurers as well as Medicare. For more information, visit

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Michael Cobble, M.D.

SOURCE Atherotech Diagnostics Lab
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use
2. Best Practices, LLC Research Highlights Critical Role of Medical Marketing in New Product Launch Success
3. Wise Sky Highlights Their Disappointment at Emergents Decision Not to Enter the China Market
4. Homeopathic Pharmacists Association Highlights the Extraordinary Safety Record of Homeopathic Medicines
5. Data Published in Proceedings of National Academy of Sciences Highlights Potential of Micromets BiTE Antibody Platform
6. Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity From Its Broad Metabolic Disease Franchise at ADA Scientific Sessions
7. Hospira Highlights a Year of Significant Progress at Its 2010 Annual Meeting of Shareholders
8. Abbott 2009 Global Citizenship Report Highlights Companys Progress in Redefining Responsibility
9. DUSA Pharmaceuticals, Inc.(R) to Host First Quarter 2010 Corporate Highlights and Financial Results Conference Call
10. LightLab Highlights OCT Market Leadership at the Society for Cardiovascular Angiography and Interventions
11. Abbott Annual Meeting Highlights Continued Strong Performance in 2009; Sustained Growth in 2010
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
(Date:11/26/2015)... -- ) has announced the ... Viscosity Drugs" report to their offering. ... of the "Self Administration of High Viscosity ... Research and Markets ( ) has ... of High Viscosity Drugs" report to their ...
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 28, 2015 , ... There is only one major question facing all law ... , This question has not been an easy question to answer. Especially when the ... the younger workforce don’t share the same discipline around working long hours. , ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an ... the University of Toronto and the University of British Columbia suggested that laws requiring ... injuries. The article explains that part of the reason for the controversial conclusion is ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... affecting the health care in America. As people age, more care is needed, ... costs are rising, and medical professionals are being overworked. The forgotten part of ...
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, from ... dispense prescription medications at home, so he invented the patent-pending ELECTRONIC M.D. , ... prescription medications. In doing so, it could help to prevent potential overdose situations. ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced ... offering customers 10% off of their purchase of lice treatment product. In addition, customers ... According to a company spokesperson. “Finding lice is a sure way to ruin the ...
Breaking Medicine News(10 mins):